Anavex Life Sciences Corp (AVXL)

[bb8675309]

Well, with fragile X as an example, we have Dr. Randi Hagerman that is supporting A2-73 in fragile X drug trial. She is not a young individual. It would be a big loss if we lose her endorsement or her voice. She talks about taking 2-73 her self for personal reasons that would help her. C-mon. imo

Dr. Randi J. Hagerman of the UC Davis MIND Institute, will be featuring Anavex 2-73 (among other potential therapies she is investigating) in her January 12th talk, The Fragile X Spectrum and new Targeted Treatments for FXS and ASD. Dr. Hagerman was the 2-73 Rett Syndrome trial Investigator at the UC Davis trial site:
Quote:
The need for treatments that improve mitochondrial function, such as Anavex 2-73 can make a difference for both neurodevelopmental disorders and neurodegenerative disorders including Rett syndrome, FXS, Parkinson Disease, Alzheimer Disease and FXTAS.

https://health.ucdavis.edu/mindinstitute/videos/images/dls/hagerman-2021-dls.pdf